Misonix to Report Fiscal 2019 Third Quarter Financial Results and Host Conference Call and Webcast on May 8
April 10, 2019 08:04 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., April 10, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
Matrix Surgical USA Receives 510(k) Clearance for OmniPore® DUROMAX® Surgical Implants for Orbital Reconstruction
October 18, 2018 17:49 ET
|
Matrix Surgical USA
ATLANTA, Ga., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Matrix Surgical USA (www.matrixsurgicalusa.com), a leader in the development, manufacturing and commercialization of craniomaxillofacial implants,...
CORRECTING and REPLACING - Misonix Reports Record Fourth Quarter and Fiscal Year 2018 Revenue
September 06, 2018 13:40 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Sept. 06, 2018 (GLOBE NEWSWIRE) -- On September 5, 2018, Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), issued a press release announcing financial results of its...
Misonix Reports Record Fourth Quarter and Fiscal Year 2018 Revenue
September 05, 2018 16:05 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...